METHOD FOR SURFACE TREATMENT AND / OR MANUFACTURING OF MEDICAL PRODUCTS AND MEDICAL PRODUCTS
The method of matte treatment, electropolishing, and electrochemical etching addresses surface defects in medical products, enhancing corrosion resistance and reducing reflectivity, resulting in improved surgical instruments.
Patent Information
- Application Number
- JP2022560964
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-04-06
- Filing Date
- 2021-04-01
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2041-04-01
AI Technical Summary
Existing surface treatment methods for medical products, such as surgical instruments, result in surface defects like notches, bumps, and material transfer, leading to reduced corrosion resistance, increased stress, and reflective properties, which are not effectively addressed by conventional techniques like belt finishing, spherical blasting, or brushing.
A method involving matte surface treatment followed by electropolishing, electrochemical etching, and further electropolishing to smooth and form a dense passivation layer, reducing microstructures and improving corrosion resistance while minimizing reflective properties.
The method enhances corrosion resistance, reduces reflective properties, and improves handling by minimizing surface defects, thereby improving the quality and usability of medical products.
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for the surface treatment or processing and / or manufacture of a medical product, and to a medical product. [Background technology]
[0002] Medical products, particularly surgical instruments and the like, are generally subjected to surface treatment before completion. For this purpose, the surface of the product is processed, for example, by slide finishing and / or belt finishing. This can remove defects in the base material and / or casting-related defects, such as decarburized areas, or surface defects, such as pores, scratches, or cracks, which would otherwise adversely affect the corrosion resistance of the product.
[0003] However, belt finishing can produce microscopic notches or ridges on the product surface. These can be inverted or flattened in subsequent processing steps. This can result in double material. Additionally, there can be another example of material transfer, for example of silicon oxide particles, from the abrasive belt to the product surface. Such material transfer, and the stresses in the medical product associated with machining, can then create or increase inherent stresses in the product. A further problem is that surface defects in the product that are not removed or created in the grinding operation can only be removed to a limited extent in downstream processing steps.
[0004] The matting of medical products can be performed using spherical blasting agents, such as glass beads. This results in a plastic deformation of the product surface, which increases in size and becomes rough. Generally, glass beads are very hard (Mohs hardness 6) and brittle, so some degree of breakage of the blasting agent occurs over time. As a result, during the matting step, both spherical and broken glass beads hit the surface of the product. Broken glass beads generate sharp notches on the product surface, while unbroken glass beads leave spherical indentations on the product surface. As a result of the collision of broken and unbroken glass beads, there is an interaction between the product surface notched by the broken glass beads and the product surface smoothed by the unbroken glass beads. This, in turn, can result in a double material. In addition to the generation of plastic deformation and corresponding inherent stresses, material transfer of the blasting agent to the product surface can occur. This material transfer is particularly pronounced in the area of the notch, where accumulated glass bead material can remain.
[0005] As an alternative to the blasting agent treatment described above using the example of glass beads, it is possible to brush the surface of the medical product. For this purpose, the product surface can be treated with a brush disc, for example using an abrasive pad or nylon fibers in a disc arrangement with abrasive particles. Typically, the brush disc is coated with aluminum oxide and / or silicon oxide particles. The brush step increases the corrosion resistance of the product surface compared to a matte product surface, but the disadvantage is that a brushed product surface has stronger reflective properties than a matte product surface.
[0006] It is also known that the microstructures or notches formed on the product surface by the double material, and any corresponding generation or increase of intrinsic stresses in the product, can adversely affect the corrosion resistance of the product. For example, in the case of material transfer during belt finishing and / or matting, an additional factor is that the transferred material can generate additional microstructures, resulting in a weakening of the passivation layer. Summary of the Invention [Problem to be solved by the invention]
[0007] (Objectives and Achievements) The object of the present invention is to provide a method for the surface treatment or processing and / or manufacture of medical products, which at least in part avoids the disadvantages arising in the common types of methods and leads in particular to medical products having high corrosion resistance, scratch resistance and reduced reflective properties.
[0008] A further object of the present invention is to provide a corresponding medical product.
[0009] The above mentioned object is achieved according to the invention by a method having the features of independent claim 1 and by a medical product as claimed in claim 14. Preferred configurations of the method and the medical product are the subject of the dependent claims and the description, all claim language of which is incorporated into the description by express reference. [Means for solving the problem]
[0010] In a first aspect, the present invention relates to a method of surface treatment or processing and / or manufacturing of a medical product, the medical product comprising or consisting of a metal or alloy, the method comprising the steps of a) matting a surface of the medical product, b) electropolishing the matte surface of the medical product, c) electrochemically etching the matte and electropolished surface of the medical product, and d) electropolishing the matte, electropolished and electrochemically etched surface of the medical product.
[0011] The method may in particular comprise the above steps in succession.
[0012] The expression "medical product" within the context of the present invention may mean a medical end product, preferably a surgical instrument, or a prototype of a medical end product, preferably a surgical instrument, in particular a semi-finished product, blank or semi-finished product, or a component of a medical end product, preferably a surgical instrument.
[0013] The term "alloy" in the context of the present invention should be understood to mean a macroscopically homogeneous metallic material composed of at least two elements (constituents), at least one of which is a metal. Thus, the term "alloy" in the context of the present invention may mean a macroscopically homogeneous metallic material composed of at least two different metals. Alternatively, the term "alloy" in the context of the present invention may mean a macroscopically homogeneous metallic material composed of at least one metal and at least one nonmetal, such as carbon.
[0014] Surprisingly, it has been found that the drawbacks initially mentioned within the context of conventional surface treatment of medical products can be partially or completely avoided by a combination of a matting step, a (first) electropolishing step, an electrochemical etching step and a further (second) electropolishing step.
[0015] The matt step thus produces a microstructure that reduces the reflection of light on the surface of the medical product. The subsequent electropolishing step results in the smoothing of this microstructure, which produces a smooth and shiny product surface. Furthermore, the electropolishing step, via the adsorption of oxygen, advantageously leads to the formation of a passivation layer, in particular a thick and dense passivation layer, on the electropolished product surface, and thus to an improvement in the corrosion resistance of the medical product. Similarly, the subsequent electrochemical etching step particularly advantageously produces an improvement in the corrosion resistance of the medical product, in particular a further improvement in the corrosion resistance. The (further) improvement in the corrosion resistance is in particular (likewise) based on the advantageous formation of a passivation layer on the product surface. Furthermore, the improvement in corrosion resistance produced by the electrochemical etching step may be the result of a reduction in corrosion-inducing material defects, and / or of compressive and tensile stresses on the surface of the medical product, and / or of the avoidance or reduction of double and / or overlapping materials. Through the formation of a preferably open microstructure on the product surface, the electrochemical etching step also results in a (new) reduction in the light reflection that is slightly increased by the (first) electropolishing step, due to the smoothing of the microstructures generated by the matting. The electrochemical etching step thus results in not only an improvement of the corrosion resistance of the medical product, but also a matting of the surface of the medical product. This significantly simplifies the handling of the medical product for the user. For example, this can prevent surgeons from being dazzled by the medical product in the operating room. The later further (second) electropolishing step preferably results in a slight smoothing of the surface of the medical product, achieving a glossy matting. As a result, improved reflective properties of the medical product can be achieved, especially without the smoothing of the microstructures generated by the electrochemical etching step.
[0016] In the case of medical products made of chromium-containing or chromium-alloy stainless steel, the basis for the positive effect of the electrochemical etching step on the light reflecting properties and corrosion resistance of the medical product is that, in particular, hexavalent chromium ions are brought into solution during the electrochemical etching operation. As a result, the chromium-rich oxide layer on the surface of the medical product is removed, which allows direct attack by the acid used for the electrochemical etching operation on chemical and physical inhomogeneities such as chromium carbide-containing areas around chromium carbides on the surface of the medical product. This gives rise to microstructures, in particular with or in the form of preferably open etching pits, on the surface of the medical product, in particular at the location of the previous chromium carbide areas. Furthermore, advantageously, a decomposition of the interface areas, in particular lath and subblock boundaries, can be made possible, which can in particular result in the protrusion of individual martensite laths. The result is a rough, in particular matte, product surface, on which the incident light can be scattered. The reduction of chromium depletion areas on the surface of the medical product also advantageously reduces the risk of the formation of nucleation sites for pitting corrosion.
[0017] A further advantage of the method relates to improved cleanability of the medical product, and in particular to a reduced tendency of the medical product to discolour its surface.
[0018] In one embodiment of the invention, a grinding operation, preferably slide finishing and / or belt finishing, on the surface of the medical product precedes the performance of step a).
[0019] For slide finishing, the medical product is introduced into the container, preferably together with the slide finishing body, preferably in the form of a bulk material, or together with an aqueous solution containing the slide finishing body and optionally additives. The optionally provided additives may be selected from the group consisting of anti-rust agents, degreasing agents, acid cleaners, separating agents (e.g. polymer beads with a diameter <1 mm), and mixtures thereof. Such a solution may advantageously take up and transport the abrasive material formed by the slide finishing body, and the abrasive product. Depending on the additives used in each case, it is possible to achieve further effects, such as protection against corrosion, degreasing, and prevention of adhesion.
[0020] The vibration or rotational movement of the container creates a relative movement between the medical product and the slide finishing body. This results in the abrasion of material of the medical product, especially at its edges. The surface image, roughness, abrasion of material and deburring performance of the medical product can advantageously be influenced in a controlled manner by the machine used for slide finishing, the grinding body and optional additives.
[0021] The slide finish body may include or be constructed of a material selected from the group consisting of ceramic, plastic, natural products such as walnut shell, steel, and combinations thereof.
[0022] In principle, the slide finish body can be of regular and / or irregular shape.
[0023] The slide finish body may in particular be free of corners and / or edges, for example in the form of an oval, annular or spherical shape.
[0024] Alternatively or in combination, the slide finishing body may have corners and / or edges. In particular, the slide finishing body may be polyhedral, for example cubic, cuboidal, prismatic, pyramidal, or parallelepiped shaped. Furthermore, the slide finishing body may in particular be configured as a straight prism and / or an oblique prism.
[0025] Alternatively, or in combination, the slide finish body may be conical and / or frusto-conical.
[0026] Furthermore, for slide finishing of medical products, a combination of different slide finishing bodies can be used. For example, it is possible to use corner and / or edgeless slide finishing bodies as well as multi-sided slide finishing bodies. Alternatively, or in combination, it is possible to use different corner and / or edgeless slide finishing bodies and / or different multi-sided slide finishing bodies. With regard to the possible configurations and shapes, reference is made entirely to the configurations and shapes described in the preceding paragraphs for the slide finishing bodies.
[0027] The slide finishing body may also have at least one dimension, in particular at least one average dimension, for example a diameter, in particular an average diameter, and / or a height, in particular an average height, and / or a length, in particular an average length, in the range of 1 mm to 80 mm. Here, it should be understood that the diameter of a spherical slide finishing body within the context of the present invention means twice the radius of a single spherical slide finishing body. In contrast, it should be understood that the diameter of a non-spherical slide finishing body within the context of the present invention means the maximum possible distance between two points that can be adopted relative to each other along a line of the circumference of a single non-spherical slide finishing body. The average dimensions referred to in this paragraph may be determined, for example, by bulk density and / or optical measurements. Slide finishing may also be performed in the form of barrel finishing, vibration finishing, plunge finishing, drag finishing, centrifugal finishing, or pressure flow wrapping.
[0028] The belt finishing of medical products is preferably carried out using an abrasive belt. For this purpose, it is possible to use, in particular, an abrasive belt running on at least two rolls. The abrasive belt preferably has a grain size of 150 to 1200. Here, the number of particles is derived from the unit of measurement mesh, i.e. the number of meshes in the grid per inch (25.4 mm). Thus, for example, an abrasive with a grain size of 150 will only pass through a sieve with 150 meshes per inch.
[0029] According to the invention, for example, first slide finishing and then belt finishing may precede the execution of step a). Belt finishing may be advantageous in particular for the treatment of so-called shadow areas of the medical product, but also outside such areas. Shadow areas define areas of the medical product where, in particular due to the geometry and / or configuration of the medical product, slide finishing bodies are not effective on the surface or only have limited effectiveness.
[0030] Alternatively, the surface of the medical product may simply be finished by slide grinding prior to carrying out step a), which may avoid the formation of notches and / or ridges on the product surface due to belt grinding and thus may further improve the corrosion resistance of the medical product.
[0031] Alternatively, the surface of the medical product may simply be finished by belt grinding prior to carrying out step a).
[0032] In a further embodiment of the present invention, during or for the execution of step a), the surface of the medical product is treated with a blasting agent, in particular a ductile, i.e. non-brittle, blasting agent. In particular, the use of a ductile blasting agent has the advantage that the generation of notches and / or microstructures, in particular in the form of microscale gaps, can be prevented or at least reduced. This can then avoid or at least reduce the occurrence of local stress peaks in the medical product, in particular further improving the corrosion resistance of the medical product. Moreover, the use of such a blasting agent can advantageously (even) improve the scratch resistance of the medical product.
[0033] In principle, the blasting agent may include or consist of a material selected from the group consisting of metals, metal oxides, alloys, ceramics, plastics, plant materials, sand, and combinations thereof.
[0034] The metal oxide may in particular be corundum (Al2O3).
[0035] The plastic may in particular be a urea resin, a phenolic resin, a polyester resin or a melamine resin.
[0036] The ceramic may in particular be a glass or a mixed ceramic.
[0037] The alloy may be a steel, in particular a stainless steel. The alloy is preferably a stainless steel, in particular a stainless steel. With regard to suitable stainless steels, reference is made to the following specifications:
[0038] The sand may in particular be garnet sand.
[0039] The blasting agent preferably comprises a metal or an alloy or is preferably composed of a metal or an alloy. With regard to suitable metals and alloys, reference is made to the above specification. Such a blasting agent has the particular advantage that it does not break and therefore does not result in any notches of the surface of the medical product. Moreover, material transfer to the product surface can be reduced or even completely avoided. Overall, this can further improve the corrosion resistance of the medical product and avoid the generation of undesirable built-in stresses in the product. Moreover, such a blasting agent is particularly suitable for increasing the scratch resistance of the medical product.
[0040] More preferably, the blasting agent comprises or is composed of steel, in particular stainless steel. Such a blasting agent may in particular provide a clear manifestation of the advantages mentioned in the last paragraph.
[0041] In principle, the blasting agent may be in the form of regularly shaped and / or irregularly shaped, in particular regularly shaped and / or irregularly shaped blasting agent bodies.
[0042] Furthermore, it is particularly preferred that the blasting agent is free of corners and / or edges, in particular in the form of a blasting agent body free of corners and / or edges, which may avoid the generation of notches on the surface of the medical product and thus further improve the corrosion resistance of the medical product.
[0043] In principle, the blasting agent can be ellipsoidal, toroidal, spherical or bead shaped or in the form of a corresponding blasting agent body.
[0044] The blasting agent is preferably in the form of spherical and / or bead shaped or spherical and / or bead shaped blasting agent bodies.
[0045] Alternatively or in combination, the blasting agent may have corners and / or edges. In particular, the blasting agent may be polyhedral, for example cubic, cuboidal, prismatic, pyramidal or parallelepipedal, or may take the form of a corresponding blasting agent body. The blasting agent may further take the form of a straight or oblique prism, or may take the form of a corresponding blasting agent body.
[0046] Alternatively, or in combination, the blasting agent may be conical and / or frusto-conical, or may take the form of a conical and / or frusto-conical blasting agent body.
[0047] Alternatively, or in combination, the blasting agent may be in the form of a sphere, for example in the form of a round wire, or in the form of a correspondingly configured blasting agent body. Particularly preferably, the blasting agent may be in the form of stainless steel wire particles.
[0048] Alternatively, or in combination, the blasting agent may be in comminuted form, in particular in the form of comminuted blasting agent bodies.
[0049] Furthermore, the blasting agent or blasting agent body may have at least one dimension, in particular at least one average dimension, for example a diameter, in particular an average diameter, and / or a height, in particular an average height, and / or a length, in particular an average length, in the range of 40 μm to 2000 μm. Here, the diameter of a spherical blasting agent or a spherical blasting agent body in the context of the present invention should be understood to mean twice the radius of the spherical blasting agent or a single spherical blasting agent body. In contrast, the diameter of a non-spherical blasting agent or a non-spherical blasting agent body in the context of the present invention should be understood to mean the maximum possible distance between two points that can be adopted relative to each other along a line around the perimeter of the non-spherical blasting agent or a single non-spherical blasting agent body. The average dimensions referred to in this paragraph may be determined, for example, by laser diffraction or sieve analysis.
[0050] The blasting agent or blasting agent body can be accelerated onto the surface of the medical product, for example, by using a jet blasting system, a jet blasting system, or a wheel blasting system. If a pressure jet or jet blasting system is used, it is possible to use pressures of 1 bar to 6 bar.
[0051] Typically, the surface of the medical product is removed at or during the performance of step b) with an anode in the electrolyte solution, which means that the medical product typically forms an anode in the electrochemical cell at or during the performance of step b).
[0052] In a further embodiment of the invention, step b) is carried out for a period of between 30 seconds and 130 seconds, in particular between 60 seconds and 100 seconds, preferably 90 seconds.
[0053] In principle, steps b) and d) can be carried out at different voltages, in particular at a DC voltage. Steps b) and d) are preferably each carried out at the same voltage, in particular at a DC voltage.
[0054] In a further embodiment of the invention, step b) and / or step d), in particular each of steps b) and d), is carried out at / with a voltage, in particular a DC voltage, of ≧2.0 V, in particular between 2.0 V and 10.0 V, preferably between 5 V and 9 V, more preferably between 7 V and 8 V. In particular, with the voltage values disclosed in this paragraph, the formation of a uniform polishing film and a uniform transfer of the metal or alloy into the electrolyte solution is achievable.
[0055] Furthermore, steps b) and / or d) may be performed at / with a constant or varying voltage, in particular a DC voltage. Regarding suitable voltage ranges / values, reference is made to the voltages disclosed in the preceding paragraph.
[0056] In a further embodiment of the invention, step b) and / or step d), in particular each of steps b) and d), is preferably performed at 5 A / dm 2 ~50A / dm 2 , especially 8A / dm 2 ~40A / dm 2 , preferably 15A / dm 2 ~20A / dm 2 The current density is set at / .
[0057] Furthermore, steps b) and / or d) may be performed more than once, in particular two, three or four times. In particular, steps b) and d) may be repeated different times. Multiple repetitions of steps b) and d) may particularly advantageously result in a uniform processing of the geometric characteristics of the medical product, e.g. the closure of the medical product, without creating a shadow on it. The closure of the medical product may for example be processed in two positions in order to create only a small shadow. Alternatively, it may be preferred that the medical product is gradually articulated during the execution of steps b) and / or d).
[0058] Alternatively, step b) and / or step d) may be performed only once.
[0059] Furthermore, the medical product may be washed and / or degreased prior to carrying out step b) and / or prior to carrying out step d).
[0060] Typically, the surface of the medical product is (likely) removed at or during the performance of step c) to be an anode in the electrolyte solution, which means that the medical product typically (likely) forms an anode in the electrochemical cell at or during the performance of step c).
[0061] In a further embodiment of the invention, step c) is carried out for a period of 30 seconds to 130 seconds, in particular 60 seconds to 100 seconds or 70 seconds to 110 seconds, preferably 90 seconds or 100 seconds. In principle, step c) can be carried out for a shorter or longer period than step b). Preferably, steps b) and d) are carried out for periods of equal length.
[0062] In a further embodiment of the invention, step c) is carried out at / with a voltage, in particular a DC voltage, measured at the anode (of the medical product to be surface treated or processed and / or manufactured) of ≦2.1 V, in particular <2 V, in particular 1.2 V to 1.8 V, preferably 1.4 V to 1.7 V, more preferably 1.4 V to 1.5 V or 1.45 V to 1.65 V. In this configuration of the invention, the advantages of the invention that are achievable by an electrochemical etching step are particularly clearly expressed. The voltage is measured at the anode (of the medical product to be surface treated or processed and / or manufactured), preferably by a silver-silver chloride electrode. The voltage ascertained is then converted to a standard hydrogen electrode. Typically, the voltage is established with a current source without knowing what part of the voltage is applied to the anode and how much is applied to the residual resistance (e.g. wire, electrolyte, etc.). In the present invention, it is preferably the exact voltage at the anode that is of great importance.
[0063] Furthermore, step c) may be performed at / with a constant or varying voltage, in particular a DC voltage. Regarding suitable voltage ranges / values, reference is made to the voltages disclosed in the preceding paragraph.
[0064] In a further embodiment of the invention, step c) is 1.4 A / dm 2 ~2.4A / dm 2 , especially 1.6A / dm 2 ~2.2A / dm 2 , preferably 1.8A / dm 2 ~2.0A / dm 2 The (low) current densities disclosed in this paragraph make it possible to control the electrochemical etching of the surface of the medical product particularly efficiently over time.
[0065] Furthermore, step c) may be carried out at a temperature between 20°C and 90°C, in particular between 50°C and 80°C, preferably between 70°C and 80°C.
[0066] Step c) is preferably repeated, in particular 2, 3 or 4 times.
[0067] Multiple repetitions of step c) may particularly advantageously result in uniform processing of the geometric characteristics of the medical product, e.g. the closure of the medical product, without creating a shadow on it. For this purpose, the closure of the medical product may for example be (identically) processed in two positions in order to create only a small shadow. Alternatively, it may be preferred that the medical product is (identically) articulated gradually during the execution of step c).
[0068] Alternatively, step c) may be performed only once.
[0069] Typically, the surface of the medical product is (likely) removed at or during the performance of step d) with an anode in the electrolyte solution, which means that the medical product typically (likely) forms an anode in the electrochemical cell at or during the performance of step d).
[0070] In a further embodiment of the invention, step d) is carried out for a shorter period of time than step b), preferably step d) is carried out for a period of 5 seconds to 20 seconds, in particular 7 seconds to 15 seconds, preferably 10 seconds.
[0071] In a further embodiment of the invention, steps b), c) and d) are each carried out using an acidic aqueous electrolyte solution, in particular comprising a mineral acid or a mixture of mineral acids, the mineral acid being preferably selected from the group consisting of phosphoric acid, sulfuric acid and a mixture of phosphoric acid and sulfuric acid, where it has been found that phosphoric acid- and / or sulfuric acid-containing aqueous electrolyte solutions are particularly advantageous for the treatment of surfaces of medical products made of stainless steel, in particular of rust-proof or corrosion-resistant stainless steel.
[0072] The aqueous acidic electrolyte solution may have a mineral acid amount of 50% to 95% by weight, in particular 60% to 95% by weight, preferably 75% to 95% by weight, based on the total weight of the aqueous acidic electrolyte solution. In particular, the aqueous acidic electrolyte solution may have a phosphoric acid amount of 20% to 70% by weight, in particular 30% to 60% by weight, preferably 40% to 50% by weight, and / or a sulfuric acid amount of 10% to 70% by weight, in particular 20% to 60% by weight, preferably 30% to 50% by weight, based in each case on the total weight of the aqueous acidic electrolyte solution.
[0073] The acidic electrolyte aqueous solution may also be an aged acidic electrolyte aqueous solution.
[0074] The acidic aqueous electrolyte solution may further comprise additives, such as surfactants.
[0075] It is also advantageous that the reactivity of the acidic electrolyte aqueous solution can be controlled via the water content of the acidic electrolyte aqueous solution. For example, the acidic electrolyte aqueous solution can have a water content of 5 wt% to 25 wt%, particularly 5 wt% to 15 wt%, and preferably 5 wt% to 10 wt%, based on the total weight of the acidic electrolyte aqueous solution.
[0076] In principle, steps b), c) and d) can each be carried out with a different aqueous acidic electrolyte solution, in particular comprising a mineral acid or a mixture of mineral acids. Alternatively, steps b) and d) can each be carried out with the same aqueous acidic electrolyte solution, in particular comprising a mineral acid or a mixture of mineral acids. In particular, the aqueous acidic electrolyte solution, in particular comprising a mineral acid or a mixture of mineral acids, during the carrying out of steps b) and d) can differ from the aqueous acidic electrolyte solution, in particular comprising a mineral acid or a mixture of mineral acids, during the carrying out of step c), in particular with respect to the mineral acid and / or the amount of mineral acid. With respect to suitable mineral acids and amounts of mineral acids, reference is made in full to the details given above.
[0077] In a further embodiment of the invention, the execution of step e) of treating the matte, electropolished, electrochemically etched and once again electropolished surface of the medical product with a passivating acid or a passivating acid-containing solution is followed by the execution of step d). In other words, in a further embodiment of the invention, the execution of step e) of passivating the matte, electropolished, electrochemically etched and once again electropolished surface of the medical product is followed by the execution of step d). In this way, it is particularly advantageously possible to further enhance or promote the formation of a passivation layer on the surface of the medical product and thus to further improve the corrosion resistance of the medical product. In the case of medical products made of chromium-containing or chromium-alloy stainless steel, for example, the passivation layer allows the formation of a thick chromium oxide layer on the surface of the medical product.
[0078] In a further embodiment of the invention, the passivating acid used is citric acid, nitric acid, and / or mixtures thereof.
[0079] The passivating acid-containing solution used during the implementation of step e) is preferably a citric acid-containing aqueous solution, in particular having a citric acid content of 5% by weight to 60% by weight, based on the total weight of the citric acid-containing aqueous solution. Alternatively, the passivating acid-containing solution used during the implementation of step e) can be a nitric acid-containing aqueous solution, in particular having a nitric acid content of 5% by weight to 60% by weight, based on the total weight of the nitric acid-containing aqueous solution.
[0080] The use of citric acid is more advantageous than the use of nitric acid, both from the standpoint of health and occupational safety. Moreover, in the case of medical products made of chromium-containing or chromium-alloyed stainless steels, it is possible to achieve a thicker chromium oxide layer with citric acid than when nitric acid is used, since the latter also reduces the proportion of other alloying elements in the case of such stainless steels.
[0081] During the implementation of step e), the medical product may for example be immersed in the passivating acid or in a passivating acid-containing solution. Alternatively, the passivating acid or in a passivating acid-containing solution may be sprayed or poured onto the surface of the medical product.
[0082] Furthermore, step e) may be carried out for a period of between 2 minutes and 2 hours, in particular between 5 minutes and 60 minutes, preferably between 10 minutes and 30 minutes.
[0083] Furthermore, step e) may be carried out within a temperature range of 20°C to 80°C, in particular 30°C to 65°C, preferably 50°C to 60°C.
[0084] Furthermore, between steps d) and e), it is possible to carry out a step de) of cleaning and / or degreasing the medical product, in particular of cleaning and / or degreasing the mattified, electropolished, electrochemically etched and once again electropolished surface of the medical product.
[0085] In a further embodiment of the invention, the execution of step f) of packaging and / or marking, in particular labelling, the medical product follows the execution of step e). Preferably, between steps e) and f), a step ef) of sterilising, in particular steam sterilising, the medical product is carried out. Alternatively, the execution of step g) of sterilising, in particular steam sterilising, the medical product follows the execution of step f).
[0086] In a further embodiment of the invention the medical product comprises or is made of steel, preferably stainless steel.
[0087] The expression "stainless steel" within the context of the present invention (in accordance with EN 10020) is understood to mean alloyed or non-alloyed steels having a certain level of purity, for example a mass fraction of sulfur and / or phosphorus ≦0.025%, in particular <0.025%.
[0088] The stainless steel may include at least one alloying element selected from the group consisting of chromium, nickel, molybdenum, titanium, niobium, tungsten, vanadium, cobalt, and combinations thereof, among others.
[0089] In particular, the stainless steel may have a chromium mass proportion of 10% to 25%.
[0090] More preferably, the stainless steel is a rust or corrosion resistant stainless steel.
[0091] More preferably, the stainless steel is a chromium-containing or chromium-alloy stainless steel. Preferably, the stainless steel is a chromium-containing corrosion-resistant stainless steel or a chromium-alloy corrosion-resistant stainless steel.
[0092] Furthermore, the stainless steel may in particular be a martensitic, ferritic, or austenitic stainless steel.
[0093] Preferably, the stainless steel is a martensitic corrosion-resistant stainless steel according to ISO 7153-1, in particular a so-called carbon martensite, i.e. a corrosion-resistant stainless steel having chromium and carbon as the main alloying components, or a so-called nickel martensite, i.e. a corrosion-resistant stainless steel having nickel as the main alloying component.
[0094] In particular, the stainless steel may be a martensitic stainless steel having a chromium proportion by mass between 10.5% and 13% and / or a carbon proportion by mass between 0.2% and 1%.
[0095] Alternatively, the stainless steel may be an austenitic stainless steel, in particular having a chromium proportion by mass between 16% and 21% and / or a carbon proportion by mass between 0.02% and 0.12%.
[0096] Alternatively, the stainless steel may be a ferritic stainless steel, in particular having a chromium mass percentage between 12% and 18% and / or a carbon mass percentage <0.2%.
[0097] For example, the stainless steel may be stainless steel with the short material designation X12Cr13 (material number 1.4006), which is a martensitic stainless steel with a carbon mass percentage of 0.08%-0.15%, a chromium mass percentage of 11.5%-13.5%, and a nickel mass percentage ≦0.75%.
[0098] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X12CrS13 (material number 1.4005), which has a carbon mass percentage of 0.08% to 0.15%, a chromium mass percentage of 12.0% to 14.0%, and a molybdenum mass percentage of ≦0.60%, optionally a sulfur mass percentage of 0.1% to 0.35%.
[0099] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X20Cr13 (material number 1.4021), which has a carbon mass percentage between 0.16% and 0.25% and a chromium mass percentage between 12.0% and 14.0%.
[0100] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X15Cr13 (material number 1.4024), which has a carbon mass percentage between 0.12% and 0.17% and a chromium mass percentage between 12.0% and 14.0%.
[0101] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X30Cr13 (material number 1.4028), which has a carbon mass percentage between 0.26% and 0.35% and a chromium mass percentage between 12.0% and 14.0%.
[0102] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X46Cr13 (material number 1.4034), which has a carbon mass percentage between 0.43% and 0.50% and a chromium mass percentage between 12.5% and 14.5%.
[0103] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X50CrMoV15 (material number 1.4116), which has a mass percentage of carbon between 0.45% and 0.55%, a mass percentage of chromium between 14.0% and 15.0%, a mass percentage of molybdenum between 0.50% and 0.80%, and a mass percentage of vanadium between 0.10% and 0.20%.
[0104] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X17CrNi16-2 (material number 1.4057), which has a carbon mass percentage between 0.12% and 0.22%, a chromium mass percentage between 15.0% and 17.0%, and a nickel mass percentage between 1.5% and 2.5%.
[0105] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X39CrMo17-1 (material number 1.4122), which has a carbon mass percentage of 0.33% to 0.45%, a chromium mass percentage of 15.5% to 17.5%, a molybdenum mass percentage of 0.8% to 1.3%, and a nickel mass percentage of ≦1.0%.
[0106] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X14CrMoS17 (material number 1.4104), which has a carbon mass percentage between 0.10% and 0.17%, a chromium mass percentage between 15.5% and 17.5%, a molybdenum mass percentage between 0.20% and 0.60%, and a sulfur mass percentage between 0.15% and 0.35%.
[0107] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X3CrNiMoV13-4 (material number 1.4313), which has a mass percentage of carbon ≦0.05%, a mass percentage of chromium between 12.0% and 14.0%, a mass percentage of molybdenum between 0.30% and 0.70%, and a mass percentage of nickel between 3.5% and 4.5%.
[0108] Alternatively, the stainless steel may be a martensitic corrosion-resistant stainless steel with the short material designation X4CrNiMo16-5-1 (material number 1.4418), which has a carbon mass percentage ≦0.06%, a chromium mass percentage between 15.0% and 17.0%, a molybdenum mass percentage between 0.80% and 1.50%, and a nickel mass percentage between 4.0% and 6.0%.
[0109] Alternatively, the stainless steel may be a martensitic stainless steel with the short material designation X65Cr13, which has a carbon mass percentage of 0.58%-0.70%, a chromium mass percentage of 12.5%-14.5%, a manganese mass percentage of ≦1.00%, a phosphorus mass percentage of 0.04%, and a sulfur mass percentage of 0.015%.
[0110] Alternatively, the stainless steel may be a martensitic stainless steel with the short material designation X30CrMoN15-1 (material number: 1.4108), which has a mass percentage of carbon between 0.25% and 0.35%, a mass percentage of chromium between 14.0% and 16.0%, a mass percentage of molybdenum between 0.85% and 1.10%, a mass percentage of nickel between 0.50%, a mass percentage of manganese between 1.00%, a mass percentage of silicon between 1.00% and 0.03% and 0.50%.
[0111] Alternatively, the stainless steel may be a martensitic stainless steel with the short material designation X70CrMo15 (material number: 1.4109), which has a carbon mass percentage of 0.60%-0.75%, a chromium mass percentage of 14.0%-16.0%, a molybdenum mass percentage of 0.40%-0.80%, a manganese mass percentage of ≦1.00%, a silicon mass percentage of ≦0.70%, a phosphorus mass percentage of 0.04%, and a sulfur mass percentage of 0.015%.
[0112] Alternatively, the stainless steel may be a martensitic stainless steel with the short material designation X90CrMoV18 (material number: 1.4112), which has a mass percentage of carbon of 0.90%, a mass percentage of chromium of 17% to 19% and a mass percentage of molybdenum of 0.90%.
[0113] Alternatively, the stainless steel may be a martensitic stainless steel with the short material designation X38CrMoV15 (material number: 1.4117), which has a mass percentage of carbon of 0.38%, a mass percentage of chromium of 14% to 15% and a mass percentage of molybdenum of 0.50%.
[0114] Alternatively, the stainless steel may be a martensitic stainless steel with the short material designation X150CrMo17 (material number: 1.4125), which has a mass percentage of carbon of 1.10%, a mass percentage of chromium of 17% and a mass percentage of molybdenum of 0.60%.
[0115] Alternatively, the stainless steel may be a martensitic stainless steel with the short material designation X22CrMoNiS13-1 (material number: 1.4121), which has a carbon mass percentage of 0.20%-0.25%, a chromium mass percentage of 12.0%-14.0%, a molybdenum mass percentage of 1.00%-1.50%, a nickel mass percentage of 0.80%-1.20%, a manganese mass percentage of 1.00%-1.50%, a silicon mass percentage of ≦1.00%, a phosphorus mass percentage of 0.045%, and a sulfur mass percentage of 0.15%-0.25%.
[0116] Alternatively, the stainless steel may be a martensitic stainless steel with the short material designation X40CrMoVN16-2 (material number: 1.4123), which has a carbon mass percentage of 0.35%-0.50%, a chromium mass percentage of 14.0%-16.0%, a molybdenum mass percentage of 1.00%-2.50%, a nickel mass percentage of 0.5%, a manganese mass percentage of ≦1.00%, a silicon mass percentage of ≦1.00%, a phosphorus mass percentage of 0.04%, and a sulfur mass percentage of 0.015%.
[0117] Alternatively, the stainless steel may be a martensitic stainless steel with the short material designation X105CrMo17 (material number: 1.4125), which has a carbon mass percentage of 0.95% to 1.20%, a chromium mass percentage of 16.0% to 18.0%, a molybdenum mass percentage of 0.04% to 0.80%, a manganese mass percentage of 1.00% or less, a silicon mass percentage of 1.00% or less, a phosphorus mass percentage of 0.040% or less, and a sulfur mass percentage of 0.15% or less.
[0118] Alternatively, the stainless steel may be a precipitation-hardened, corrosion-resistant stainless steel with the short material designation X5CrNiCuNb16-4 (material number: 1.4542), which has a mass percentage of carbon ≦0.07%, a mass percentage of chromium 15.0% to 17.0%, a mass percentage of molybdenum ≦0.60%, a mass percentage of nickel 3.0% to 5.0%, a mass percentage of copper 3.0% to 5.0%, and a mass percentage of niobium ≦0.45%.
[0119] Alternatively, the stainless steel may be a precipitation-hardened, corrosion-resistant stainless steel with the short material designation X7CrNiAl17-7 (material number: 1.4568), which has a mass percentage of carbon ≦0.09%, a mass percentage of chromium between 16.0% and 18.0%, a mass percentage of nickel between 6.5% and 7.8%, and a mass percentage of aluminum between 0.70% and 1.50%.
[0120] Alternatively, the stainless steel may be a precipitation-hardened, corrosion-resistant stainless steel with the short material designation X5CrNiMoCuNb14-5 (material number: 1.4594), which has a mass percentage of carbon ≦0.07%, a mass percentage of chromium between 13.0% and 15.0%, a mass percentage of molybdenum between 1.20% and 2.00%, a mass percentage of nickel between 5.0% and 6.0%, a mass percentage of copper between 1.20% and 2.00%, and a mass percentage of niobium between 0.15% and 0.60%.
[0121] Alternatively, the stainless steel may be a precipitation-hardened, corrosion-resistant stainless steel with the short material designation X3CrNiTiMb12-9 (material number: 1.4543), which has a mass percentage of carbon ≦0.03%, a mass percentage of chromium 11.0%-12.5%, a mass percentage of molybdenum ≦0.50%, a mass percentage of nickel 3.00%-5.00%, a mass percentage of titanium ≦0.90%-1.40%, a mass percentage of copper 1.50%-2.50%, a mass percentage of niobium 0.10%-0.50%, a mass percentage of manganese 0.50%, a mass percentage of silicon 0.50%, a mass percentage of phosphorus ≦0.02%, and a mass percentage of sulfur ≦0.015%.
[0122] Alternatively, the stainless steel may be a ferritic corrosion-resistant stainless steel with the short material designation X2CrNi12 (material number: 1.4003), which has a carbon mass percentage ≦0.03%, a chromium mass percentage between 10.5% and 12.5%, a nickel mass percentage between 0.3% and 1.00%, and a nitrogen mass percentage ≦0.03%.
[0123] Alternatively, the stainless steel may be a ferritic corrosion-resistant stainless steel with the short material designation X2CrNi12 (material number: 1.4512), which has a carbon mass percentage of ≦0.03%, a chromium mass percentage of 10.5% to 12.5%, and a titanium mass percentage of ≦0.65%.
[0124] Alternatively, the stainless steel may be a ferritic corrosion-resistant stainless steel with the short material designation X6Cr17 (material number: 1.4016), which has a carbon mass percentage of ≦0.08% and a chromium mass percentage of 16.0% to 18.0%.
[0125] Alternatively, the stainless steel may be a ferritic corrosion-resistant stainless steel with the short material designation X3CrTi17 (material number: 1.4510), which has a carbon mass percentage ≦0.05%, a chromium mass percentage between 16.0% and 18.0%, and a titanium mass percentage of ≦0.80%.
[0126] Alternatively, the stainless steel may be a ferritic corrosion-resistant stainless steel with the short material designation X6CrMoS17 (material number: 1.4105), which has a mass percentage of carbon ≦0.08%, a mass percentage of chromium 16.0% to 18.0%, a mass percentage of molybdenum 0.20% to 0.60%, and a mass percentage of sulfur 0.15% to 0.35%.
[0127] Alternatively, the stainless steel may be a ferritic corrosion-resistant stainless steel with the short material designation X3CrNb17 (material number: 1.4511), which has a mass percentage of carbon ≦0.05%, a mass percentage of chromium between 16.0% and 18.0%, and a mass percentage of niobium less than or equal to 1.00%.
[0128] Alternatively, the stainless steel may be a ferritic corrosion-resistant stainless steel with the short material designation X2CrTiNb18 (material number: 1.4509), which has a carbon mass percentage ≦0.03%, a chromium mass percentage between 17.5% and 18.5%, a niobium mass percentage less than or equal to 1.00%, and a titanium mass percentage between 0.10% and 0.60%.
[0129] Alternatively, the stainless steel may be a ferritic corrosion-resistant stainless steel with the short material designation X6CrMo17-1 (material number: 1.4113), which has a carbon mass percentage ≦0.08%, a chromium mass percentage between 16.0% and 18.0%, and a molybdenum mass percentage between 0.90% and 1.40%.
[0130] Alternatively, the stainless steel may be a ferritic corrosion-resistant stainless steel with the short material designation X2CrMoTi18-2 (material number: 1.4521), which has a mass percentage of carbon ≦0.025%, a mass percentage of chromium between 17.0% and 20.0%, a mass percentage of molybdenum between 1.80% and 2.50%, and a mass percentage of titanium less than or equal to 0.80%.
[0131] Alternatively, the stainless steel may be an austenitic-ferritic corrosion-resistant stainless steel with the short material designation X2CrNi22-2 (material number: 1.4062), which has a mass percentage of carbon ≦0.03%, a mass percentage of chromium 21.5% to 24.0%, a mass percentage of molybdenum ≦0.45%, a mass percentage of nickel 1.00% to 2.90%, and a mass percentage of nitrogen 0.16% to 0.28%.
[0132] Alternatively, the stainless steel may be an austenitic-ferritic corrosion-resistant stainless steel with the short material designation X2CrMnNiN21-5-1 (material number: 1.4162), which has a mass percentage of carbon ≦0.04%, a mass percentage of chromium 21.0%-22.0%, a mass percentage of molybdenum 0.10%-0.80%, a mass percentage of nickel 1.35%-1.70%, a mass percentage of manganese 4.0%-6.0%, a mass percentage of nitrogen 0.20%-0.25%, and a mass percentage of copper 0.10%-0.80%.
[0133] Alternatively, the stainless steel may be an austenitic-ferritic corrosion-resistant stainless steel with the short material designation X2CrNiN23-4 (material number: 1.4362), which has a mass percentage of carbon ≦0.03%, a mass percentage of chromium 22.0%-24.0%, a mass percentage of molybdenum 0.10%-0.60%, a mass percentage of nickel 3.5%-5.5%, and a mass percentage of copper 0.10%-0.60%.
[0134] Alternatively, the stainless steel may be an austenitic-ferritic corrosion-resistant stainless steel with the short material designation X2CrNiMoN22-5-3 (material number: 1.4462), which has a mass percentage of carbon ≦0.03%, a mass percentage of chromium 21.0%-23.0%, a mass percentage of molybdenum 2.5%-3.5%, a mass percentage of nickel 4.5%-6.5%, and a mass percentage of nitrogen 0.10%-0.22%.
[0135] Alternatively, the stainless steel may be an austenitic-ferritic corrosion-resistant stainless steel with the short material designation X2CrNiMnMoCuN24-4-3-2 (material number: 1.4662), which has a carbon mass percentage ≦0.03%, a chromium mass percentage of 23.0% to 25.0%, a molybdenum mass percentage of 1.00% to 2.00%, a nickel mass percentage of 3.0% to 4.5%, a manganese mass percentage of 2.5% to 4.0%, and a copper mass percentage of 0.10% to 0.80%.
[0136] Alternatively, the stainless steel may be an austenitic-ferritic corrosion-resistant stainless steel with the short material designation X2CrNiMoN25-7-4 (material number: 1.4410), which has a mass percentage of carbon ≦0.03%, a mass percentage of chromium 24.0%-26.0%, a mass percentage of molybdenum 3.0%-4.5%, a mass percentage of nickel 6.0%-8.0%, and a mass percentage of nitrogen 0.24%-0.35%.
[0137] Alternatively, the stainless steel may be an austenitic-ferritic corrosion-resistant stainless steel with the short material designation X2CrNiMoCuWN25-7-4 (material number: 1.4501), which has a mass percentage of carbon ≦0.03%, a mass percentage of chromium 24.0%-26.0%, a mass percentage of molybdenum 3.0%-4.0%, a mass percentage of nickel 6.0%-8.0%, a mass percentage of copper 0.50%-1.00%, a mass percentage of tungsten 0.50%-1.00%, and a mass percentage of nitrogen 0.20%-0.30%.
[0138] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X2CrNiMo18-15-3 (material number: 1.4441), which has a carbon mass percentage of 0.030% or less, a chromium mass percentage of 17.0% to 19.0%, a molybdenum mass percentage of 2.70% to 3.0%, a nickel mass percentage of 13.0% to 15.0%, a manganese mass percentage of 2.00% or less, a copper mass percentage of 0.50% or less, a silicon mass percentage of 0.75% or less, a phosphorus mass percentage of 0.025% or less, a sulfur mass percentage of 0.003% or less, and a nitrogen mass percentage of 0.10% or less.
[0139] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X5CrNi18-10 (material number: 1.4301), which has a mass percentage of carbon ≦0.07%, a mass percentage of chromium between 17.5% and 19.5%, a mass percentage of nickel between 8.0% and 10.5%, and a mass percentage of nitrogen ≦0.11%.
[0140] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X4CrNi18-12 (material number: 1.4303), which has a mass percentage of carbon ≦0.06%, a mass percentage of chromium 17.0% to 19.0%, a mass percentage of nickel 11.0% to 13.0%, and a mass percentage of nitrogen ≦0.11%.
[0141] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X8CrNiS18-9 (material number: 1.4305), which has a carbon mass percentage ≦0.10%, a chromium mass percentage 17.0% to 19.0%, a nickel mass percentage 8.0% to 10.0%, a sulfur mass percentage 0.15% to 0.35%, and a copper mass percentage ≦1.00%.
[0142] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X2CrNi19-11 (material number: 1.4306), which has a mass percentage of carbon ≦0.030%, a mass percentage of chromium between 18.0% and 20.0%, a mass percentage of nickel between 10.0% and 12.0%, and a mass percentage of nitrogen ≦0.11%.
[0143] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X2CrNi18-9 (material number: 1.4307), which has a mass percentage of carbon ≦0.030%, a mass percentage of chromium between 17.5% and 19.5%, a mass percentage of nickel between 8.0% and 10.5%, and a mass percentage of nitrogen ≦0.11%.
[0144] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X2CrNi18-10 (material number: 1.4311), which has a mass percentage of carbon ≦0.030%, a mass percentage of chromium between 17.5% and 19.5%, a mass percentage of nickel between 8.5% and 11.5%, and a mass percentage of nitrogen between 0.12% and 0.22%.
[0145] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X6CrNiTi18-10 (material number: 1.4541), which has a carbon mass percentage ≦0.08%, a chromium mass percentage between 17.0% and 19.0%, a nickel mass percentage between 9.0% and 12.0%, and a titanium mass percentage less than or equal to 0.70%.
[0146] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X6CrNiNb18-10 (material number: 1.4550), which has a carbon mass percentage ≦0.08%, a chromium mass percentage between 17.0% and 19.0%, a nickel mass percentage between 9.0% and 12.0%, and a niobium mass percentage less than or equal to 1.00%.
[0147] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X3CrNiCu18-9-4 (material number: 1.4567), which has a carbon mass percentage ≦0.04%, a chromium mass percentage of 17.0% to 19.0%, a nickel mass percentage of 8.5% to 10.5%, and a copper mass percentage of 3.0% to 4.0%.
[0148] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X10CrNi18-8 (material number: 1.4310), which has a carbon mass percentage of 0.05% to 0.15%, a chromium mass percentage of 16.0% to 19.0%, a molybdenum mass percentage of ≦0.80%, and a nickel mass percentage of 6.0% to 9.5%.
[0149] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X5CrNiMo17-12-2 (material number: 1.4401), which has a mass percentage of carbon ≦0.07%, a mass percentage of chromium 16.5% to 18.5%, a mass percentage of molybdenum 2.00% to 2.50%, a mass percentage of nickel 10.0% to 13.0%, and a mass percentage of nitrogen ≦0.10%.
[0150] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X2CrNiMo17-12-2 (material number: 1.4404), which has a mass percentage of carbon ≦0.030%, a mass percentage of chromium 16.5% to 18.5%, a mass percentage of molybdenum 2.00% to 2.50%, a mass percentage of nickel 10.0% to 13.0%, and a mass percentage of nitrogen ≦0.10%.
[0151] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X6CrNiMoTi17-12-2 (material number: 1.4571), which has a carbon mass percentage ≦0.08%, a chromium mass percentage of 16.5% to 18.5%, a molybdenum mass percentage of 2.00% to 2.50%, a nickel mass percentage of 10.5% to 13.5%, and a titanium mass percentage of 0.70% or less.
[0152] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X2CrNiMoN17-13-3 (material number: 1.4429), which has a mass percentage of carbon ≦0.030%, a mass percentage of chromium 16.5% to 18.5%, a mass percentage of molybdenum 2.5% to 3.0%, a mass percentage of nickel 11.0% to 14.0%, and a mass percentage of nitrogen 0.12% to 0.22%.
[0153] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X2CrNiMo18-14-3 (material number: 1.4435), which has a carbon mass percentage ≦0.030%, a chromium mass percentage 17.0% to 19.0%, a molybdenum mass percentage 2.5% to 3.0%, a nickel mass percentage 12.5% to 15.0%, and a nitrogen mass percentage ≦0.10%.
[0154] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X3CrNiMo17-13-3 (material number: 1.4436), which has a mass percentage of carbon ≦0.05%, a mass percentage of chromium 16.5% to 18.5%, a mass percentage of molybdenum 2.5% to 3.0%, a mass percentage of nickel 10.5% to 13.0%, and a mass percentage of nitrogen ≦0.10%.
[0155] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X2CrNiMoN17-13-5 (material number: 1.4439), which has a mass percentage of carbon ≦0.030%, a mass percentage of chromium 16.5% to 18.5%, a mass percentage of molybdenum 4.0% to 5.0%, a mass percentage of nickel 12.5% to 14.5%, and a mass percentage of nitrogen 0.12% to 0.22%.
[0156] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X1NiCrMoCu25-20-5 (material number: 1.4539), which has a mass percentage of carbon ≦0.020%, a mass percentage of chromium 19.0% to 21.0%, a mass percentage of molybdenum 4.0% to 5.0%, a mass percentage of nickel 24.0% to 26.0%, a mass percentage of copper 1.20% to 2.00%, and a mass percentage of nitrogen ≦0.15%.
[0157] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X2CrNiMnMoNbN25-18-5-4 (material number: 1.4565), which has a mass percentage of carbon ≦0.030%, a mass percentage of chromium 24.0%-26.0%, a mass percentage of molybdenum 4.0%-5.0%, a mass percentage of nickel 16.0%-19.0%, a mass percentage of manganese 5.0%-7.0%, a mass percentage of nitrogen 0.30%-0.60%, and a mass percentage of niobium ≦0.15%.
[0158] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X1NiCrMoCuN25-20-7 (material number: 1.4529), which has a mass percentage of carbon ≦0.020%, a mass percentage of chromium 19.0%-21.0%, a mass percentage of molybdenum 6.0%-7.0%, a mass percentage of nickel 24.0%-26.0%, a mass percentage of copper 0.50%-1.50%, and a mass percentage of nitrogen 0.15%-0.25%.
[0159] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X1CrNiMoCuN20-18-7 (material number: 1.4547), which has a mass percentage of carbon ≦0.020%, a mass percentage of chromium 19.5%-20.5%, a mass percentage of molybdenum 6.0%-7.0%, a mass percentage of nickel 17.5%-18.5%, a mass percentage of copper 0.50%-1.00%, and a mass percentage of nitrogen 0.18%-0.25%.
[0160] Alternatively, the stainless steel may be an austenitic corrosion-resistant stainless steel with the short material designation X1CrNiMoCuN24-22-8 (material number: 1.4652), which has a carbon mass percentage ≦0.020%, a chromium mass percentage 23.0%-25.0%, a molybdenum mass percentage 7.0%-8.0%, a nickel mass percentage 21.0%-23.0%, a manganese mass percentage 2.0%-4.0%, and a nitrogen mass percentage 0.45%-0.5.
[0161] In a further embodiment of the invention, the medical product is a medical device, preferably a surgical device. The device may further be a reusable device or a disposable device.
[0162] Additionally, the device may be a minimally invasive device, ie, a device that can be used in minimally invasive surgery.
[0163] The surgical instrument may be selected from the group consisting of dilating instruments, grasping instruments, clamping instruments, cutting instruments, suturing devices, endoscopes, and combination instruments, among others.
[0164] The expansion device can be, for example, a surgical hook, a retractor, a wound spreader, a sternal spreader, a wound closure, a speculum, or a trocar sleeve.
[0165] The grasping device may be, for example, a set of tweezers, a clamp, a needle holder, or a set of grasping forceps.
[0166] The clamping device may be, for example, a soft clamp, particularly for temporary obstruction of the intestine and small ducts, or a pre-clamp.
[0167] The cutting instrument may be, for example, a scalpel, a knife, a set of scissors, a set of diverging forceps, a set of bone fragment forceps, a set of ring forceps, an electrocautery, turbinate scissors, a cautery instrument, or an ultrasonic knife.
[0168] The suturing device may be, inter alia, a stapler or a staple remover.
[0169] The combined instrument can be, for example, an endostapler or stapler that clamps and precisely cuts hollow organs at the same time. Additionally, the combined instrument can be a combined needle holder that can both grip and cut, as well as a universal suturing device.
[0170] Additionally, the surgical instrument may be a hammer.
[0171] Furthermore, the surgical instrument may be a chisel, in particular a flat chisel or a gouge such as a bone gouge, or a curette, in particular a bone curette.
[0172] Additionally, the surgical instrument may be a probe.
[0173] Additionally, the surgical instrument may be a bone punch.
[0174] Additionally, the surgical instrument may be a lever or elevator, or a raspati.
[0175] In a second aspect, the present invention relates to a medical product comprising or consisting of a metal or alloy, which is produced or producible by a method according to the first aspect of the invention and / or which has at least one of the following characteristics: - a pitting potential (measured against a standard hydrogen electrode) of 100 mV to 1200 mV, in particular 200 mV to 800 mV, preferably 400 mV to 500 mV, and / or a contact angle of -80° to 140°, in particular 90° to 130°, preferably 100° to 120°, and / or - a passivation layer, in particular of chromium oxide, having a thickness of 1 nm to 10 nm, in particular 3 nm to 10 nm, preferably 5 nm to 10 nm, coating at least a part, in particular only a part or completely, of the surface of the medical product.
[0176] The aforementioned pitting potentials and contact angles are particularly advantageous with respect to corrosion resistance of medical products.
[0177] The expression "pitting potential" within the context of the present invention is understood to mean the electrochemical potential that can be determined using an electrochemical cell using a three-electrode configuration. The pitting potential is characterized by a sudden increase in current and represents the breakdown of the passive layer at the onset of pitting. An increase in the pitting potential leads to an improvement in corrosion resistance through a reduction in the tendency for pitting. The pitting potential can be measured according to ASTM G5-13-1 or DIN EN ISO10993-15.
[0178] The expression "contact angle" within the context of the present invention should be understood to mean the angle formed by a droplet of liquid on the surface of the medical product relative to the surface of the medical product. A reduced contact angle corresponds to a reduced contact of the droplet on the surface of the medical product. A reduced contact angle particularly advantageously leads to an improvement in the corrosion resistance and cleanability of the medical product.
[0179] The contact angle can be measured according to ASTM D7334-08. Alternatively, the contact angle measurement can be performed by a contact angle measuring instrument from dataPhysics (Contact Angle System OCA15 Plus) using a 0.9% sodium chloride solution (B.Braun) with a drop volume of 1 μl. For the contact angle measurement, the samples in this case are washed in the normal manufacturing process and can be washed with deionized water in an ultrasonic bath for 5 minutes before the measurement, and immediately before the measurement, the samples are rinsed with deionized water and blown dry with oil-free compressed air.
[0180] The medical product is preferably a medical device, preferably a surgical device.
[0181] With regard to further features and advantages of the medical product, in order to avoid repetition, full reference is made to the details given in the context of the first aspect of the invention. The features and advantages described therein with respect to the method and medical product are also applicable mutatis mutandis to the medical product according to the second aspect of the invention.
[0182] Further features and advantages of the present invention will be apparent from the claims and the description of preferred embodiments with reference to the following examples, where the features of the present invention can be implemented individually by themselves or in combination with each other. The embodiments described below serve to further clarify the present invention, without the present invention being limited thereto. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0183] Example Section 1. Surface treatment of surgical instruments or representative samples thereof by the method of the present invention The specimens used were produced with the same material (X20Cr13) and the same manufacturing steps as the surgical instruments (e.g. clamps, needle holders, scissors with hard metal, etc.).
[0184] SEM / EDX analysis (foreign and doublet materials) was performed on the instrument.
[0185] Potentiodynamic tests (spot corrosion potential) were also performed on the equipment.
[0186] Contact angle measurements (contact angle) were performed on sample plaques (flat surfaces without shadows).
[0187] Scratch resistance measurements (amount of abrasion scars) were performed on the sample plaques by pin-on-disk experiments.
[0188] Prior to surface treatment, surgical instruments and sample plaques according to the current production chain of surgical instruments were molded and heat treated.
[0189] For subsequent surface treatment, the surgical instrument (Aesculap BH110R clamp) and the sample plaque were first treated with a slide finish in an acidic solution for a period of 4 hours, and then polished with a slide finish in an aqueous solution for a period of 1 hour.
[0190] The surgical instruments and the sample plaques were then treated by blasting. The blasting agent used was stainless steel wire particles with an average spherical diameter of 300 μm. A spray blasting system was used for blasting. The blasting was carried out under a pressure of 2 bar.
[0191] The surfaces of the surgical instruments and the sample plaques were subsequently electrochemically treated at 80 °C in an electrolyte composed of phosphoric acid (38 wt% - 58 wt%) and sulfuric acid (26.6 wt% - 52.0 wt%). For this purpose, a current of 18.5 A / dm 2 A current density of 1.9 A / dm was initially employed. Electropolishing was carried out for a period of 90 seconds. A voltage of 5-6 volts was then established. Then, a current density of 1.9 A / dm was applied. 2 The operation was continued at a current density of 18.5 A / dm. Electrochemical etching was carried out for a period of 90 seconds. A voltage of 1.8 to 2.1 volts was then established. Finally, the current density was 18.5 A / dm. 2 A current density of 0.01 V was once again employed. Electropolishing was carried out for a period of 10 seconds. A voltage of 5-6 volts was now established.
[0192] The surfaces of the surgical instruments and the samples were then passivated. For this purpose, the surgical instruments and the sample plaques were immersed in 14.4% by weight nitric acid. Passivation was carried out at a temperature of 40° C. for a period of 10 minutes.
[0193] Finally, the device and sample plaques were dried in air at 80° C. for 10 minutes.
[0194] As a result of the surface treatment of the surgical instruments and test specimens, no double or overlapping materials and no foreign material transfer was detectable. The instruments had a pitting potential of 565 mV. The sample plaques had a contact angle of 106.8°. The amount of wear damage was not measurable because the wear was too low.
[0195] 2. Surface treatment of surgical instruments by common types of methods The surgical instruments (Aesculap BH110R clamps) and sample plaques were first treated with slide finishing for a period of 4 hours. Afterwards, the surgical instruments and sample plaques were polished for a period of 1 hour.
[0196] The surgical instruments and specimens were then treated by blasting. For this purpose, glass beads with an average diameter of 40 μm to 70 μm were used. Blasting was carried out in a spray blasting system under a pressure of 4 bar.
[0197] The surgical instruments and the specimens were subsequently passivated. For this purpose, a 10% by weight citric acid solution was used. Passivation was carried out at a temperature of 55° C. for a period of 10 minutes.
[0198] As a result of the surface preparation of the surgical instruments and the sample plaques, many instances of double or overlapping material were detectable. Additionally, 1.2% foreign material transfer was detected. The pitting potential of the corroded specimen was 356 mV. Additionally, the sample plaques had a contact angle of 66.0°. The amount of material removed in the wear scar was 55244 μm. 3 It was.
[0199] 3. Conclusion The above comparison of the method of the present invention and the general type method shows that the method of the present invention leads to a product with better corrosion resistance, especially better scratch resistance. Moreover, the method of the present invention can reduce the risk of surface discoloration compared to the general type method. Furthermore, the method of the present invention leads to a product with better cleanability (see the contact angle measured). The following items are elements that are claimed in the international application: (Item 1) A method for the surface treatment and / or manufacture of a medical product, said medical product comprising or consisting of a metal or alloy, said method comprising the following steps: a) matting a surface of the medical product; b) electropolishing the matte surface of the medical product; c) electrochemically etching the brushed, electropolished surface of the medical product; d) electropolishing the brushed, electropolished and electrochemically etched surface of the medical product; and Equipped with Step b) and step d) are performed at a voltage of 2.0 V to 10.0 V and / or at 5 A / dm 2 ~50A / dm 2 and step c) is performed at a voltage of 1.2 V to 1.8 V and / or a current density of 1.4 A / dm 2 ~2.4A / dm 2 The method is characterized in that it is carried out at a current density of (Item 2) 2. The method according to item 1, characterized in that a grinding operation, preferably slide finishing and / or belt finishing, on the surface of the medical product precedes the execution of step a). (Item 3) 3. The method according to item 1 or 2, characterized in that step a) is carried out by treating the surface of the medical product with a blasting agent, in particular a ductile blasting agent and / or a blasting agent without corners and / or edges, in particular a blasting agent comprising or consisting of a metal or an alloy. (Item 4) 4. The method according to any one of items 1 to 3, characterized in that step b) is carried out for a period of 30 seconds to 130 seconds, in particular 60 seconds to 100 seconds, preferably 90 seconds. (Item 5) Steps b) and d) are each performed at a voltage of 5V to 9V, more preferably 7V to 8V, and / or at a current of 8A / dm 2 ~40A / dm 2 , preferably 15A / dm 2 ~20A / dm 2 The method according to any one of items 1 to 4, characterized in that the method is carried out at a current density of (Item 6) 6. The method according to any one of items 1 to 5, characterized in that step c) is carried out for a period of 30 seconds to 130 seconds, in particular 70 seconds to 110 seconds, preferably 100 seconds. (Item 7) Step c) is a voltage applied to the anode of 1.4 V to 1.7 V, more preferably 1.45 V to 1.65 V, and / or 1.6 A / dm 2 ~2.2A / dm 2 , preferably 1.8A / dm 2 ~2.0A / dm2 The method according to any one of items 1 to 6, characterized in that the method is carried out at a current density of (Item 8) 8. The method according to any one of items 1 to 7, characterized in that step d) is carried out for a shorter period than step b), preferably for a period of 5 seconds to 20 seconds, in particular for a period of 7 seconds to 15 seconds, preferably for a period of 10 seconds. (Item 9) 9. The method according to any one of items 1 to 8, characterized in that steps b), c) and d) are each carried out using an acidic aqueous electrolyte solution, in particular comprising a mineral acid, in particular selected from the group consisting of phosphoric acid, sulfuric acid and a mixture of phosphoric acid and sulfuric acid. (Item 10) 10. The method according to any one of items 1 to 9, characterized in that the implementation of step e) of treating the matte, electropolished, electrochemically etched and once again electropolished surface of the medical product with a passivating acid or a passivating acid-containing solution follows the implementation of step d). (Item 11) 11. The method according to item 10, characterized in that the passivating acid used is citric acid and / or nitric acid. (Item 12) 12. The method according to any one of claims 1 to 11, characterized in that the execution of step f) of packaging the medical product follows the execution of step e), and step ef) of sterilizing the medical product takes place between steps e) and f), or the execution of step g) of sterilizing the medical product follows the execution of step f). (Item 13) 13. The method according to any one of claims 1 to 12, characterized in that the medical product is made of stainless steel, in particular a chromium-containing stainless steel, preferably a chromium-containing corrosion-resistant stainless steel, in particular a martensitic corrosion-resistant stainless steel. (Item 14) 14. A medical product produced or producible by the method according to any one of items 1 to 13, comprising or consisting of a metal or alloy, comprising a passivation layer having a thickness of 1 nm to 10 nm coating at least a part of said surface of said medical product. (Item 15) 15. Medical product according to item 14, characterized in that the medical product is a medical device, in particular a surgical device.
Claims
1. A method for the surface treatment and / or manufacture of a medical product, said medical product comprising or consisting of a metal or alloy, said method comprising the following steps: a) matting a surface of the medical product; b) electropolishing the matte surface of the medical product; c) electrochemically etching the brushed, electropolished surface of the medical product; d) electropolishing the brushed, electropolished and electrochemically etched surface of the medical product; Equipped with Steps b) and d) each include a voltage of 2.0 V to 10.0 V and / or a current of 5 A / dm 2 ~50A / dm 2 and step c) is performed at a voltage of 1.2 V to 1.8 V and / or a current density of 1.4 A / dm 2 ~2.4A / dm 2 The method is characterized in that it is carried out at a current density of
2. 2. The method of claim 1, wherein a grinding operation on the surface of the medical product precedes the performance of step a).
3. 3. The method according to claim 1 or 2, characterized in that step a) is carried out by treating the surface of the medical product with a blasting agent.
4. A method according to any one of claims 1 to 3, characterised in that step b) is carried out for a period of between 30 seconds and 130 seconds.
5. Steps b) and d) are performed at a voltage of 5 V to 9 V and / or at 8 A / dm 2 The method according to any one of claims 1 to 4, characterized in that it is carried out at a current density of up to 40 A / dm2.
6. A method according to any one of claims 1 to 5, characterised in that step c) is carried out for a period between 30 seconds and 130 seconds.
7. Step c) is a voltage applied to the anode of 1.4 V to 1.7 V and / or 1.6 A / dm 2 The method according to any one of claims 1 to 6, characterized in that it is carried out at a current density of up to 2.2 A / dm2.
8. The method according to any one of claims 1 to 7, characterized in that step d) is carried out for a shorter period of time than step b).
9. The method according to any one of claims 1 to 8, characterized in that steps b), c) and d) are each carried out using an acidic aqueous electrolyte solution.
10. 10. The method according to any one of claims 1 to 9, characterized in that the implementation of step e) of treating the matte, electropolished, electrochemically etched and once again electropolished surface of the medical product with a passivating acid or a passivating acid-containing solution follows the implementation of step d).
11. 11. The method according to claim 10, characterized in that the passivating acid used is citric acid and / or nitric acid.
12. 12. The method according to claim 10 or 11, characterized in that the execution of step f) of packaging the medical product follows the execution of step e), and that step ef) of sterilizing the medical product takes place between steps e) and f), or that the execution of step g) of sterilizing the medical product follows the execution of step f).
13. The method according to any one of claims 1 to 12, characterized in that the medical product is made of stainless steel.
Citation Information
Patent Citations
A kind of surface treatment method of medical degradable metal interventional stent
CN106048707B
Stent device for spinal fusion
WO2017151548A1
